Evidence mapPaperPMID 42073229Full record

ReviewFoods (Basel, Switzerland)2026

Infrastructure for Sustainable Protein Innovation: A Global Value Chain Framework for CDMOs in Fermentation-Based Biomanufacturing.

Germano Glufke Reis, Antonella Samoggia, Maria Clara Manzoki

Abstract readReview
In one paragraph

Review in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Germano Glufke ReisSFoodLab-Sustainable Food Value Chains Laboratory, School of Management, Federal University of Parana, Curitiba 80210-170, Parana, Brazil.ORCID 0000-0001-8884-5734
Antonella SamoggiaDepartment of Agricultural and Food Sciences, University of Bologna, Viale Fanin 50, 40137 Bologna, Italy.ORCID 0000-0003-3930-6173
Maria Clara ManzokiBioprocesses Engineering and Biotechnology Department, Federal University of Parana, Curitiba 80210-170, Parana, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Achieving more sustainable production in emerging biomanufacturing sectors depends not only on technological innovation but also on how production systems are organized, governed, and scaled. Fermentation-derived proteins produced through biomass and precision fermentation offer promising pathways to reduce the environmental impacts of conventional livestock production. However, their sustainability and circularity outcomes depend heavily on access to biomanufacturing infrastructure and coordination along global value chains. Drawing on Global Value Chain (GVC) theory and an integrative review of more than 40 academic and industry sources published between 2017 and 2026, spanning global value chain governance, biomanufacturing scale-up, CDMO functions, and sustainability and bioeconomy transitions, this study develops a conceptual framework that positions Contract Development and Manufacturing Organizations (CDMOs) as key infrastructural intermediaries in fermentation-based protein systems. CDMOs facilitate access to fermentation capacity, technical expertise, and regulatory capabilities, thereby shaping governance arrangements, capability development, and the scaling of innovation. In doing so, they influence how cleaner production principles, such as resource efficiency, circular feedstock integration, and improved environmental performance, are translated into industrial practice. The analysis also highlights risks linked to CDMO-driven scaling, including infrastructure concentration, dependency dynamics, and unequal access across regions. By integrating GVC perspectives with insights from sustainability transitions and the circular bioeconomy, the article advances understanding of how infrastructural intermediaries shape cleaner production outcomes in emerging biomanufacturing value chains.

Indexed as

alternative protein scalingbiomanufacturingcircular productioncontract development and manufacturing organizationsfermentation-based proteinsglobal value chainsinnovation governancesustainable food systems

Identifiers

PMID42073229
PMCPMC13114431

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.